Cargando…
Interaction between Bacteria and the Immune System for Cancer Immunotherapy: The α-GalCer Alliance
Non-conventional T cells, such as γδ T and invariant natural killer T (iNKT) cells, are emerging players in fighting cancer. Alpha-galactosylceramide (α-GalCer) is used as an exogenous ligand to activate iNKT cells. Human cells don’t have a direct pathway producing α-GalCer, which, however, can be p...
Autores principales: | Ustjanzew, Arsenij, Sencio, Valentin, Trottein, François, Faber, Jörg, Sandhoff, Roger, Paret, Claudia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9180740/ https://www.ncbi.nlm.nih.gov/pubmed/35682578 http://dx.doi.org/10.3390/ijms23115896 |
Ejemplares similares
-
Synthesis of a 2''-Deoxy-β-GalCer
por: Thakur, Meena S., et al.
Publicado: (2014) -
α-GalCer and iNKT Cell-Based Cancer Immunotherapy: Realizing the Therapeutic Potentials
por: Zhang, Yingting, et al.
Publicado: (2019) -
A Multifactorial Mechanism in the Superior Antimalarial Activity of α-C-GalCer
por: Schmieg, John, et al.
Publicado: (2010) -
Galactosylsphingamides: new α-GalCer analogues to probe the F’-pocket of CD1d
por: Guillaume, Joren, et al.
Publicado: (2017) -
6″-Modifed α-GalCer-peptide conjugate vaccine candidates protect against liver-stage malaria
por: Meijlink, Michael A., et al.
Publicado: (2022)